Envista Holdings NVST
NYSE NVST
$27.20 +0.27 (+1.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Envista Holdings (NVST) Amortization of Deferred Charges (2020 - 2026)

Envista Holdings (NVST) posted quarterly Amortization of Deferred Charges of $9.1 million for Q2 2026, up 727.27% year-over-year from $1.1 million in Q2 2025, and down 71.11% quarter-over-quarter from $31.5 million in Q4 2025.

Envista Holdings (NVST) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Envista Holdings' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $9.1 million for Q2 2026.

  • In Q2 2026, Amortization of Deferred Charges rose 727.27% year-over-year to $9.1 million; the TTM figure through Apr 2026 stood at $42.0 million (up 357.67% YoY), while the FY2025 annual figure was $34.7 million, up 608.16% from the prior year.
  • Amortization of Deferred Charges for Q2 2026 stood at $9.1 million, down from $31.5 million in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $31.5 million in Q4 2025, with the low at -$18.2 million in Q4 2024.
  • The 5-year median for Amortization of Deferred Charges is $800000.0 (2022), against an average of $3.9 million.
  • The sharpest annual moves came in 2024 and 2026: Amortization of Deferred Charges slumped 1616.67% in 2024, then soared 727.27% in 2026.
  • Envista Holdings' Amortization of Deferred Charges stood at $21.3 million in 2022, then tumbled by 94.37% to $1.2 million in 2023, then plunged by 1616.67% to -$18.2 million in 2024, then surged by 273.08% to $31.5 million in 2025, then sank by 71.11% to $9.1 million in 2026.
  • Business Quant data shows NVST's Amortization of Deferred Charges at $9.1 million in Q2 2026, $31.5 million in Q4 2025, and $700000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Envista Holdings 4.40 Bn 3.27 Bn 407.00 Mn

Historic Data

Download Data
DateValue
Jul 3, 2026 700,000.00
Jul 3, 2026 700,000.00
Apr 3, 2026 9.10 Mn
Apr 3, 2026 9.10 Mn
Dec 31, 2025 31.50 Mn
Dec 31, 2025 31.50 Mn
Sep 26, 2025 700,000.00
Sep 26, 2025 700,000.00
Jun 27, 2025 700,000.00
Jun 27, 2025 700,000.00
Mar 28, 2025 1.10 Mn
Mar 28, 2025 1.10 Mn
Dec 31, 2024 -18.20 Mn
Dec 31, 2024 -18.20 Mn
Sep 27, 2024 100,000.00
Sep 27, 2024 100,000.00
Jun 28, 2024 700,000.00
Jun 28, 2024 700,000.00
Mar 29, 2024 7.30 Mn
Mar 29, 2024 7.30 Mn